Plasma metabolite profiling reveals potential biomarkers of giant cell tumor of bone by using NMR-based metabolic profiles: A cross-sectional study

Giant cell tumor (GCT) of bone is a locally aggressive bone tumor, which accounts for 4% to 5% of all primary bone tumors. At present, the early diagnosis and postoperative recurrence monitoring are still more difficult due to the lack of effective biomarkers in GCT. As an effective tool, metabolomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wei, Liu, Xilin, Wu, Juan, Kang, Xia, Xie, Qingyun, Sheng, Jun, Xu, Wei, Liu, Da, Zheng, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783185/
https://www.ncbi.nlm.nih.gov/pubmed/31577769
http://dx.doi.org/10.1097/MD.0000000000017445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783185/
https://www.ncbi.nlm.nih.gov/pubmed/31577769
http://dx.doi.org/10.1097/MD.0000000000017445

Ejemplares similares